CloudMD Is My TeleHealth Stock
Source: Keith Schaefer for Streetwise Reports  (4/28/20)
With telehealth becoming a rising star in the coronavirus era, Keith Schaefer discusses why one company rapidly expanding in Canada stands out. More >

SmileDirectClub Awarded US Patent for SmileShop Concept and Plans to Reopen Stores in May
Source: Streetwise Reports  (4/28/20)
SmileDirectClub shares traded 20% higher after the company reported it has been awarded a U.S. patent for its SmileShop retail concept and treatment process and that it plans to reopen stores on a rolling basis starting in May. More >

Avadel Shares Rise and Shine on Positive Phase 3 Narcolepsy Study Findings
Source: Streetwise Reports  (4/27/20)
Avadel Pharmaceuticals' shares traded 25% higher reaching a new 52-week high price after the company reported positive topline results from its Pivotal Phase 3 REST-ON trial of FT218 for the treatment of excessive daytime sleepiness and cataplexy in narcolepsy patients. More >

Mesoblast Shares Soar 120% After Reporting 83% Survival Rate in COVID-19 Patients with ARDS
Source: Streetwise Reports  (4/24/20)
Shares of Mesoblast more than doubled and set a new 52-week high price after the company reported that it achieved a 83% survival rate in New York ventilator-dependent COVID-19 patients with moderate to severe acute respiratory distress syndrome who were treated with its allogeneic cell therapy remestemcel-L. More >

West Pharma Services' Shares Rise 10% on Q1 Sales Growth and Raised FY Earnings Guidance
Source: Streetwise Reports  (4/23/20)
Shares of West Pharmaceutical Services traded higher and established a new 52-week high price after the firm reported Q1/20 earnings that included a 10.8% increase in YoY revenues. More >

Biopharma Approved to Launch COVID-19 Trial in South Korea
Source: Streetwise Reports  (4/23/20)
Algernon Pharmaceuticals will evaluate one of its drugs in coronavirus-infected patients with severe pneumonia. More >

BARDA Award Provides 'Lift-off for Biotech's COVID Vaccine'
Source: Streetwise Reports  (4/22/20)
The ways in which Moderna is to use the funds are explained and an update on its coronavirus vaccine is provided in a ROTH Capital Partners report. More >

Biopharma Reports Consistent 'Phase 2 Liver Fat (NASH and NAFLD) Results'
Source: Streetwise Reports  (4/22/20)
The new data are reviewed and updates are provided on Can-Fite BioPharma's other clinical studies, including one for COVID-19, in this Dawson James research report. More >

Exelixis Shares Climb 21% on Positive Phase 3 Advanced Kidney Cancer Study Results
Source: Streetwise Reports  (4/20/20)
Shares of Exelixis reached a new 52-week high price after the firm reported positive topline results from its Pivotal Phase 3 CheckMate -9ER trial evaluating Opdivo® (nivolumab) in combination with CABOMETYX® (cabozantinib) in previously untreated advanced renal cell carcinoma. More >

Biotech to Test Stem Cell Product in COVID-19-Caused Acute Respiratory Distress
Source: Streetwise Reports  (4/15/20)
A description of Mesoblast's multi-site clinical trial and possible implication for the therapeutic are provided in an H.C. Wainwright & Co. report. More >

Lifeway Foods' Shares Rise 40% on Positive Q1 Sales Data with March Revenue Up 13% Y-O-Y
Source: Streetwise Reports  (4/15/20)
Shares of Lifeway Foods traded higher as the company reported it has increased production to support accelerated demand during the COVID-19 health crisis. More >

MEI Pharma Shares Rise 50% on $682.5M Partnership with Japanese Company to Treat B-cell Malignancies
Source: Streetwise Reports  (4/14/20)
Shares of MEI Pharma traded higher after the company announced that it has entered into development and global licensing agreement with Kyowa Kirin for its oral selective PI3Kδ inhibitor (ME-401) used for treating B-cell malignancies. More >

CytoSorbents Shares Trade 20% Higher as FDA Grants CytoSorb EUA for COVID-19
Source: Streetwise Reports  (4/13/20)
Shares of CytoSorbents traded higher setting a new 52-week intraday high price after the company reported that the FDA granted emergency use authorization for CytoSorb for use in patients with COVID-19. More >

Vir Partners with Samsung Biologics on Large-Scale Manufacture of COVID-19 Antibody Treatment
Source: Streetwise Reports  (4/10/20)
Vir Biotechnology reported it has entered into an agreement with Samsung Biologics valued at $362 million for large-scale manufacture of SARS-COV-2 antibodies for potential COVID-19 treatment. Though U.S. markets are closed for the Good Friday holiday, Samsung Biologics shares traded nearly 17% higher today on the Korean Stock exchange. More >

MediciNova Shares Rise 40% on Plans to Initiate COVID-19 ARDS Clinical Trial
Source: Streetwise Reports  (4/9/20)
Shares of MediciNova traded higher after the company reported that it plans to initiate a clinical study of MN-166 (ibudilast) for COVID-19 acute respiratory distress syndrome. More >

Company Secures Largest Order to Date for Antibiotic-Free Feedstock Supplement
Source: Streetwise Reports  (4/8/20)
Avivagen Inc. has secured its largest ever order of OxC-betaâ„¢ Livestock from its long-standing Philippine partner UNAHCO. More >

Biopharma's Technology Could Render Drug Suitable for COVID-19 Treatment
Source: Streetwise Reports  (4/8/20)
How this could be achieved using the proprietary platform of TFF Pharmaceuticals and why it could work are discussed in a ROTH Capital Partners report. More >

Novavax Announces Its First-in-Human Coronavirus Vaccine Trial Will Begin in Mid-May
Source: Streetwise Reports  (4/8/20)
Shares of Novavax traded 20% higher setting a new 52-week high price after the company reported that it has accelerated initiation of a Phase 1 clinical trial for its coronavirus vaccine candidate NVX-CoV2373. The study will commence in mid-May with preliminary results expected in July 2020. More >

Telemedicine Platform Grows to More Than 100,000 Registered Users
Source: Streetwise Reports  (4/8/20)
CloudMD attributed record weekly new user registrations to social distancing protocols and advised that it now has greater than 100,000 registered users on its telemedicine platforms. More >

Immunomedics Shares Double as Phase 3 Breast Cancer Trial Achieves 'Compelling' Efficacy Data
Source: Streetwise Reports  (4/6/20)
Shares of Immunomedics opened 117% higher after the company reported that it has stopped its Phase 3 ASCENT study of sacituzumab govitecan after recording "compelling evidence of efficacy" in heavily pretreated patients with metastatic triple-negative breast cancer. More >

Animal Feed Supplement Maker Expands Asia Footprint
Source: Streetwise Reports  (4/4/20)
Avivagen receives new orders from two eastern countries for its product. More >

Fate Therapeutics Shares Rise 10% as First Person Treated with Its Anti-Cancer Therapy
Source: Streetwise Reports  (4/3/20)
Shares of Fate Therapeutics traded higher after the firm reported it has treated the first patient in a first-in-human trial of FT596 for patients with B-cell malignancies and chronic lymphocytic leukemia. More >

Three COVID-19 Patients Treated with PLX Cells
Source: Streetwise Reports  (4/1/20)
Two programs, one new and the other ongoing, involving Pluristem Therapeutics' regenerative products are reviewed in a Dawson James report. More >

Healthcare Firm Expands Telemedicine App to Ontario as Coronavirus Concerns Accelerate Demand
Source: Streetwise Reports  (4/1/20)
CloudMD reported that it has launched its telemedicine app in Ontario as coronavirus concerns have greatly increased the need for digital healthcare. More >

Chembio Launches COVID-19 Test that Provides Quick Results from a Simple Finger Stick
Source: Streetwise Reports  (4/1/20)
Chembio Diagnostics shares traded higher and set a new 52-week high price after the company reported that it has launched a DPP® COVID-19 serological point-of-care test which can deliver IgM/IgG antibody results in 15 minutes using a simple finger stick. More >